FDA Approved: ETHACRYNATE SODIUM — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved Ethacrynate Sodium as an original ANDA for Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• ETHACRYNATE SODIUM (ethacrynate sodium)

Snippet

ORIG AP for ETHACRYNATE SODIUM (ETHACRYNATE SODIUM)